Botanical Solution Inc. (BSI) Secures $6.1 Million in Series A First Closing

Funding Rounds

▤ Summary

Quillibrium® was launched in Peru last year with great success and will soon reach growers across Mexico through BSI’s main distribution partner Syngenta. This new funding will also accelerate market readiness of new botanical biopesticide products currently in later development stages and enable the expansion of BSI’s R&D pipeline. For pharmaceutical markets, BSI’s new funding will vastly increase the quantity of Quillaja saponaria plants that can be grown at BSI’s labs and the sustainable production of billions of doses of gold standard adjuvant QS-21, traditionally obtained from old native trees that are increasingly affected by climate change and strict deforestation laws in Chile. BSI, a Delaware Corporation has a proprietary R&D platform for truly sustainable and improved production of consistent and high- quality Advanced Botanical Materials (ABM). Otter was an early and consistent investor in AgraQuest, a leading biopesticide company where Mr. Pasquesi served as chairman of the board of directors.

$ Funding

$
Amount - Total raised
□
Date - Announcement date
◎
Investors British Standards Institution Lead investors
▥
Company - Funded company

▥ Classifications

industries
Fintech & Banking
applications
Data Management

◇ AskAI Classifications

Labels
No AI classifications detected

▦ Linked Companies

BSI Group
$500M to $1B